Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids
Clinical trial NCT00589823 · COMPLETED
Trial details
- NCT number
- NCT00589823
- Sponsor
- Archimedes Development Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-03-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.